These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 17894367)

  • 21. Novel MR image contrast mechanisms in epilepsy.
    Tofts PS
    Magn Reson Imaging; 1995; 13(8):1099-106. PubMed ID: 8750322
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Myelin water imaging of multiple sclerosis at 7 T: correlations with histopathology.
    Laule C; Kozlowski P; Leung E; Li DK; Mackay AL; Moore GR
    Neuroimage; 2008 May; 40(4):1575-80. PubMed ID: 18321730
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Denoising by averaging reconstructed images: application to magnetic resonance images.
    Luo J; Zhu Y; Magnin IE
    IEEE Trans Biomed Eng; 2009 Mar; 56(3):666-74. PubMed ID: 19389683
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Measuring injury and repair of myelin and neurons in multiple sclerosis.
    Arnold DL; Chen J
    Ernst Schering Res Found Workshop; 2005; (53):173-86. PubMed ID: 16315614
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Trauma, stress, and multiple sclerosis.
    Poser CM
    Bull Am Acad Psychiatry Law; 1979; 7(3):209-18. PubMed ID: 549692
    [No Abstract]   [Full Text] [Related]  

  • 26. Difference in disease burden and activity in pediatric patients on brain magnetic resonance imaging at time of multiple sclerosis onset vs adults.
    Waubant E; Chabas D; Okuda DT; Glenn O; Mowry E; Henry RG; Strober JB; Soares B; Wintermark M; Pelletier D
    Arch Neurol; 2009 Aug; 66(8):967-71. PubMed ID: 19667217
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [MRI and metabolic brain pathology].
    Adamsbaum C; Aubourg P
    JBR-BTR; 2005; 88(5):249-50. PubMed ID: 16302338
    [No Abstract]   [Full Text] [Related]  

  • 28. Measuring demyelination and remyelination in acute multiple sclerosis lesion voxels.
    Giacomini PS; Levesque IR; Ribeiro L; Narayanan S; Francis SJ; Pike GB; Arnold DL
    Arch Neurol; 2009 Mar; 66(3):375-81. PubMed ID: 19273757
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Complementary information from multi-exponential T2 relaxation and diffusion tensor imaging reveals differences between multiple sclerosis lesions.
    Kolind SH; Laule C; Vavasour IM; Li DK; Traboulsee AL; Mädler B; Moore GR; Mackay AL
    Neuroimage; 2008 Mar; 40(1):77-85. PubMed ID: 18226549
    [TBL] [Abstract][Full Text] [Related]  

  • 30. What you see depends on how you look: Gray matter lesions in multiple sclerosis.
    Chard DT; Miller DH
    Neurology; 2009 Sep; 73(12):918-9. PubMed ID: 19692676
    [No Abstract]   [Full Text] [Related]  

  • 31. Diagnostics: Getting a clear picture.
    Graber C
    Nature; 2012 Apr; 484(7393):S7. PubMed ID: 22509508
    [No Abstract]   [Full Text] [Related]  

  • 32. Measurement of signal-to-noise ratios in sum-of-squares MR images.
    Gilbert G
    J Magn Reson Imaging; 2007 Dec; 26(6):1678; author reply 1679. PubMed ID: 18059007
    [No Abstract]   [Full Text] [Related]  

  • 33. One-dimensional-ratio measures of atrophy progression in multiple sclerosis as evaluated by longitudinal magnetic resonance imaging.
    Martola J; Stawiarz L; Fredrikson S; Hillert J; Bergström J; Flodmark O; Aspelin P; Wiberg MK
    Acta Radiol; 2009 Oct; 50(8):924-32. PubMed ID: 19639474
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Rate of ventricular enlargement in multiple sclerosis: a nine-year magnetic resonance imaging follow-up study.
    Martola J; Stawiarz L; Fredrikson S; Hillert J; Bergstrom J; Flodmark O; Aspelin P; Kristoffersen Wiberg M
    Acta Radiol; 2008 Jun; 49(5):570-9. PubMed ID: 18568545
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Denoising human cardiac diffusion tensor magnetic resonance images using sparse representation combined with segmentation.
    Bao LJ; Zhu YM; Liu WY; Croisille P; Pu ZB; Robini M; Magnin IE
    Phys Med Biol; 2009 Mar; 54(6):1435-56. PubMed ID: 19218737
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Visualizing the cause of gray matter atrophy in multiple sclerosis.
    Richert ND; Kraft E; Stüve O
    Arch Neurol; 2009 Feb; 66(2):159-60. PubMed ID: 19204151
    [No Abstract]   [Full Text] [Related]  

  • 37. Uncovering and characterizing multiple sclerosis lesions: the aid of fluid-attenuated inversion recovery images in the presence of gadolinium contrast agent.
    Bagnato F
    J Neuroimaging; 2009 Jul; 19(3):201-4. PubMed ID: 19187471
    [No Abstract]   [Full Text] [Related]  

  • 38. MR in the diagnosis and monitoring of multiple sclerosis: an overview.
    Rovira A; León A
    Eur J Radiol; 2008 Sep; 67(3):409-14. PubMed ID: 18434066
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The pathologic substrate of magnetic resonance alterations in multiple sclerosis.
    Lassmann H
    Neuroimaging Clin N Am; 2008 Nov; 18(4):563-76, ix. PubMed ID: 19068402
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Fractal dimension analysis of grey matter in multiple sclerosis.
    Esteban FJ; Sepulcre J; de Miras JR; Navas J; de Mendizábal NV; Goñi J; Quesada JM; Bejarano B; Villoslada P
    J Neurol Sci; 2009 Jul; 282(1-2):67-71. PubMed ID: 19167728
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.